speb/financial-data huggingface dataset:
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6187276000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 904882000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 904882000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 5575000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 30494000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 30494000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Trading Securities: 71742000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Trading Securities: 71742000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Work In Process: 586195000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 586195000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Working Capital: 6587181000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 6587181000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1477284000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4252388000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 537415000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.20
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2623647000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 90251000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 90251000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 537415000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.20
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 107483000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — EBIT: 195542000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — EBITDA: 285793000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1628741000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 40378000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 40378000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -6583000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Income: 107483000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 107483000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 114066000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 107483000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 107483000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 114066000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -40378000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -40378000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 285793000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 107483000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Operating Income: 151457000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4252388000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 44085000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 530702000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 155164000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2623647000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 90251000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 303964000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 303964000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 41098000.00
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
MOREPENLAB.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 4100931000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1279703000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 4115758000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2427394000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2735405000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 64789000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 544994667.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.75
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 132250000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 331897000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 932857000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 11962337000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 255439000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2641917000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 10369904000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 72982000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1253851000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1326833000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4644027000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 193935000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 112808000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 112808000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 544994667.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.75
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 408746000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — EBIT: 498755000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — EBITDA: 611563000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 0.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1107117000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3860540000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1473841000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 41806000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 41806000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 2721155000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 13414709000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1015950000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 59268000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 198521000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 257789000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 389981000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 7125000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -1689000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1120475000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Income: 408746000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 408746000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 410435000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 408746000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 408746000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 410435000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -41806000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -41806000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3860540000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10855220000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 69923000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 353309000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 176780330.99
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Operating Income: 194138000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 4115758000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3975691000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 358400000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 10866496000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1107117000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1006451000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 46363000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 461732000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3605101000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 4796000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 600960000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Other Special Charges: -258254000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2427394000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 456949000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2641917000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 112808000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 138638000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 138638000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 547953699.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 258254000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11962337000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 10855220000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 26288330.99
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 46514000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.10
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 17361394000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 12160858000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1584622000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11969462000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3921620000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5391932000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 6991490000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 747905000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 258254000.00
MOREPENLAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 258254000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Trading Securities: 951161000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 5725877000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1508932000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4841610000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 550186000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.50
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2973335000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 103818000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 103818000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 550186000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.50
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 275093000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — EBIT: 397399000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — EBITDA: 501217000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1868275000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 43187000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 43187000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 138000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Income: 275093000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 275093000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 274955000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 275093000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 275093000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 274955000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -43187000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -43187000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 501217000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 275093000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Operating Income: 359343000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4841610000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 38056000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 586092000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 354212000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2973335000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 103818000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 198077000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 198077000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 79257000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 4482267000.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — +Operating Expense: 5930808000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1664889000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — +Total Revenue: 18056915000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4847159000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3172380000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3172380000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 3331375000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3331375000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 548420809.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 562307143.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Basic EPS: 1.73
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.28
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 273812000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1605428000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 131647000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 131647000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 311897000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 311897000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1076749000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1076749000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -108579000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 175646000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 297344000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1427549000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -954559000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 66237000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1095841000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -108579000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 12464387000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 12464387000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 215514000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 215514000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 11234165000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2995266000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Current Assets: 11636141000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 11636141000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 89039000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 89039000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt: 610899000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 610899000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 699938000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 699938000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 4903021000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4903021000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 296388000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 296388000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Depreciation: 364347000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 364347000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 364347000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 57470000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 364347000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 57470000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 548420809.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 562307143.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Diluted EPS: 1.73
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.28
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 948768000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 157446000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — EBIT: 1363337000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — EBIT: 271641000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — EBITDA: 1727684000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — EBITDA: 329111000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — End Cash Position: 311897000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 973977000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -1279008000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -10959000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -247295000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 90000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill: 0.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 0.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1189603000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1189603000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 4155949000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4155949000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Gross Profit: 6822750000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1851893000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Interest Expense: 164137000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 38766000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 164137000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 38766000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -164137000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Inventory: 2718263000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2718263000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 14411292000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 14411292000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1234160000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1012867000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1012867000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 1317818000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 42608000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 42608000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1336006000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1336006000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1378614000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1378614000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 1317818000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -73227000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 412390000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 412390000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 6511000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 6511000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Minority Interests: -7697000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 437000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 306459000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1635008000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1635008000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -2000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Income: 948768000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Income: 157446000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 948768000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 157446000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 956465000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 157009000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 948768000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 157446000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 948768000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 157446000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1199200000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 956465000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 157009000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -750195000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: -164137000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -38766000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 487432000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 1153744000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 1244591000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -164137000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -38766000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 149752000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -433163000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 4155949000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 4155949000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -844693000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -90847000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 11274784000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 11274784000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 164588000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 164588000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 75544000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 75544000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1469430000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 329111000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 742788253.41
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 157446000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 326420000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Operating Income: 891942000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 187004000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 18056915000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 4847159000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 547953699.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -28152000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 4505203000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4505203000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 381095000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 381095000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 11368546000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 11368546000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1189603000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1189603000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 164137000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1290267000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1290267000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 213141000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 84637000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2249307000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 670781000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Properties: 3940435000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3940435000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 4551000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4551000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 764852000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 764852000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Other Special Charges: -258254000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Payables: 3172380000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3172380000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 71952000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Pretax Income: 1199200000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 232875000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -750195000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -855233000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 11234165000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2995266000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 364347000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 57470000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -73227000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 306459000.00
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 10540000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 989760000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 349081000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 989760000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 349081000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Share Issued: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 547953699.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Special Income Charges: 258254000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 12464387000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12464387000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 11274784000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 11274784000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 52274253.41
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Tax Provision: 242735000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 75866000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.20
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.33
MOREPENLAB.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -252794000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Assets: 19361201000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 19361201000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 13800393000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 13800393000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2078552000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2078552000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 12470898000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12470898000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Total Expenses: 17164973000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4660155000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 6890303000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6890303000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 7725060000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7725060000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1987282000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1987282000.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 258254000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MOREPENLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 258254000.00
MOREPENLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Trading Securities: 1012867000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Trading Securities: 1012867000.00
MOREPENLAB.NS balance_sheet (annual, 2026-03-31) — Working Capital: 6733120000.00
MOREPENLAB.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 6733120000.00
MORG.OL cash_flow (annual, 2021-12-31) — Interest Paid Cff: -268000000.00
MORG.OL cash_flow (annual, 2021-12-31) — Interest Received Cfi: 94000000.00
MORG.OL balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 67000000.00
MORG.OL cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -3727000000.00
MORG.OL cash_flow (annual, 2021-12-31) — Purchase Of Investment: -10013000000.00
MORG.OL cash_flow (annual, 2021-12-31) — Sale Of Investment: 6286000000.00
MORG.OL income_statement (annual, 2021-12-31) — Special Income Charges: -45000000.00
MORG.OL income_statement (annual, 2021-12-31) — Total Unusual Items: -45000000.00
MORG.OL income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -45000000.00
MORG.OL income_statement (annual, 2021-12-31) — Write Off: 45000000.00
MORG.OL income_statement (annual, 2022-12-31) — +Operating Expense: 701000000.00
MORG.OL income_statement (annual, 2022-12-31) — +Total Revenue: 1755000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -242000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 358000000.00
MORG.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 49304029.00
MORG.OL income_statement (annual, 2022-12-31) — Basic EPS: 15.13
MORG.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 428000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 297000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -35000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 989000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 394000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 394000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -158000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Cash Flowsfromusedin Operating Activities Direct: -3299000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Changes In Cash: -34000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Classesof Cash Payments: -22366000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Classesof Cash Receiptsfrom Operating Activities: 19067000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Common Stock: 989000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -158000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 8102000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 126000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 752000000.00
MORG.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 49304029.00
MORG.OL income_statement (annual, 2022-12-31) — Diluted EPS: 15.13
MORG.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 746000000.00
MORG.OL cash_flow (annual, 2022-12-31) — End Cash Position: 394000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 11259000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3214000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Free Cash Flow: -3334000000.00
MORG.OL income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 319000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 56000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Gross PPE: 444000000.00
MORG.OL income_statement (annual, 2022-12-31) — Interest Expense: 1213000000.00
MORG.OL income_statement (annual, 2022-12-31) — Interest Income: 2745000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Interest Paid Cff: -702000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Invested Capital: 43781000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Investing Cash Flow: 51000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 12246000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Investments And Advances: 12246000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 0.00
MORG.OL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 8624000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 35679000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 8624000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3895000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
MORG.OL balance_sheet (annual, 2022-12-31) — Net Debt: 35285000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Income: 777000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 746000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 777000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 777000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 777000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 777000000.00
MORG.OL income_statement (annual, 2022-12-31) — Net Interest Income: 1532000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 4729000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 4729000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -655000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Net PPE: 202000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -35000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 8046000000.00
MORG.OL income_statement (annual, 2022-12-31) — Normalized Income: 811960000.00
MORG.OL cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3299000000.00
MORG.OL income_statement (annual, 2022-12-31) — Operating Revenue: 1755000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 49283843.00
MORG.OL cash_flow (annual, 2022-12-31) — Other Cash Paymentsfrom Operating Activities: -15317000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Other Cash Receiptsfrom Operating Activities: 11000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Other Equity Interest: 4551000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 56000000.00
MORG.OL income_statement (annual, 2022-12-31) — Other Operating Expenses: 212000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Other Properties: 147000000.00
MORG.OL income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 31000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Payables: 210000000.00
MORG.OL income_statement (annual, 2022-12-31) — Pretax Income: 1013000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -35000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Receivables: 33000000.00
MORG.OL income_statement (annual, 2022-12-31) — Rent And Landing Fees: 22000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3895000000.00
MORG.OL cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
MORG.OL income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 37000000.00
MORG.OL income_statement (annual, 2022-12-31) — Selling General And Administration: 37000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Share Issued: 49434770.00
MORG.OL income_statement (annual, 2022-12-31) — Special Income Charges: -46000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 8102000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 8046000000.00
MORG.OL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -11040000.00
MORG.OL income_statement (annual, 2022-12-31) — Tax Provision: 236000000.00
MORG.OL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.24
MORG.OL balance_sheet (annual, 2022-12-31) — Total Assets: 89501000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Total Capitalization: 43781000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Total Debt: 35679000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 8102000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 81399000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 210000000.00
MORG.OL income_statement (annual, 2022-12-31) — Total Unusual Items: -46000000.00
MORG.OL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -46000000.00
MORG.OL balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 150927.00
MORG.OL balance_sheet (annual, 2022-12-31) — Treasury Stock: 3000000.00
MORG.OL income_statement (annual, 2022-12-31) — Write Off: 46000000.00
MORG.OL income_statement (annual, 2023-12-31) — +Operating Expense: 858000000.00
MORG.OL income_statement (annual, 2023-12-31) — +Total Revenue: 2195000000.00